Abstract:As a result of thrombosis or intimal hyperplasia, synthetic artificial vascular grafts had a low success rate when they were used to replace small-diameter arteries (inner diameter < 6 mm). C-type natriuretic peptides (CNP) have anti-thrombotic effects, and can promote endothelial cell (EC) proliferation and in-hibit vascular smooth muscle cell (SMC) over-growth. In this study, poly(epsilon-caprolactone) (PCL) vascular grafts loaded with CNP (PCL-CNP) were constructed by electrospinning. The PCL-CNP grafts were able to continuously release CNP at least 25 days in vitro . The results of scanning electron microscopy (SEM) and mechanical testing showed that the loading of CNP did not change the microstructure and mechani-cal properties of the PCL grafts. In vitro blood compatibility analysis displayed that PCL-CNP grafts could inhibit thrombin activity and reduce platelet adhesion and activation. In vitro cell experiments demon-strated that PCL-CNP grafts activated ERK1/2 and Akt signaling in human umbilical vein endothelial cells (HUVECs), as well as increased cyclin D1 expression, enhanced proliferation and migration, and increased vascular endothelial growth factor (VEGF) secretion and nitric oxide (NO) production. The rabbit arteri-ovenous (AV)-shunt ex vitro indicated that CNP loading significantly improved the antithrombogenicity of PCL grafts. The assessment of vascular grafts in rat abdominal aorta implantation model displayed that PCL-CNP grafts promoted the regeneration of ECs and contractile SMCs, modulated macrophage polariza-tion toward M2 phenotype, and enhanced extracellular matrix remodeling. These findings confirmed for the first time that loading CNP is an effective approach to improve the hemocompatibility and vascular regeneration of synthetic vascular grafts.Statement of significanceSmall-diameter (< 6 mm) vascular grafts (SDVGs) have not been made clinically available due to their prevalence of thrombosis, limited endothelial regeneration and intimal hyperplasia. The incorporation of bioactive molecules into SDVGs serves as an effective solution to improve hemocompatibility and en-dothelialization. In this study, for the first time, we loaded C-type natriuretic peptides (CNP) into PCL grafts by electrospunning and confirmed the effectiveness of loading CNP on improving the hemocompat-ibility and vascular regeneration of artificial vascular grafts. Regenerative advantages included enhance-ment of endothelialization, modulation of macrophage polarization toward M2 phenotypes, and improved contractile smooth muscle cell regeneration. Our investigation brings attention to CNP as a valuable bioac-tive molecule for modifying cardiovascular biomaterial.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Nitric Oxide-Releasing Poly(ε-Caprolactone)/s-nitrosylated Keratin Biocomposite Scaffolds for Potential Small-Diameter Vascular Grafts.

Nitric Oxide Releasing Poly(vinyl Alcohol)/s-Nitrosated Keratin Film As a Potential Vascular Graft

A Small-Diameter Vascular Graft Promotes Rapid and Benign Remodeling of the Neointima Through Dual Release of Nitric Oxide and Hydrogen Sulfide

Nitrate-Functionalized poly(ε-Caprolactone) Small-Diameter Vascular Grafts Enhance Vascular Regeneration via Sustained Release of Nitric Oxide

Nitrate-Functionalized poly(-Caprolactone) Small-Diameter Vascular Grafts Enhance Vascular Regeneration <i>via</i> Sustained Release of Nitric Oxide

Preparation and Assessment of Nitric Oxide‐Releasing Small‐Diameter Collagen‐Based Vascular Graft for Vascular Regeneration Applications

Rapid in situ endothelialization of a small diameter vascular graft with catalytic nitric oxide generation and promoted endothelial cell adhesion.

Bioinspired, Artificial, Small-Diameter Vascular Grafts with Selective and Rapid Endothelialization Based on an Amniotic Membrane-Derived Hydrogel.

Bilayer Vascular Grafts with On-Demand NO and H2S Release Capabilities.

Catalytic generation of nitric oxide from poly(ε-caprolactone)/phosphobetainized keratin mats for vascular tissue engineering scaffold.

Core-shell Fibrous Vascular Grafts with the Nitric Oxide Releasing Property

Facile Fabrication of Copper-Incorporating Poly(ε-Caprolactone)/keratin Mats for Tissue-Engineered Vascular Grafts with the Potential of Catalytic Nitric Oxide Generation.

Polycaprolactone/gelatin Degradable Vascular Grafts Simulating Endothelium Functions Modified by Nitric Oxide Generation

The Grafts Modified by Heparinization and Catalytic Nitric Oxide Generation Used for Vascular Implantation in Rats

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H<sub>2</sub>S for Anti-Inflammation and Anticalcification

Long-term nitric oxide release for rapid endothelialization in expanded polytetrafluoroethylene small-diameter artificial blood vessel grafts

Heparinized PCL/keratin Mats for Vascular Tissue Engineering Scaffold with Potential of Catalytic Nitric Oxide Generation

Endothelium-Mimicking Bilayer Vascular Grafts with Dual-Releasing of NO/H2S for Anti-Inflammation and Anticalcification

The loading of C-type natriuretic peptides improved hemocompatibility and vascular regeneration of electrospun poly(-caprolactone) grafts

Regulation of Macrophage Polarization and Promotion of Endothelialization by NO Generating and PEG-YIGSR Modified Vascular Graft.

Nanofibrous Vascular Scaffold Prepared from Miscible Polymer Blend with Heparin/stromal Cell-Derived Factor-1 Alpha for Enhancing Anticoagulation and Endothelialization